Home
>
US Stocks
>
Accuray Incorporated

Accuray Incorporated (ARAY)

$3.58

-0.11

(-2.98%)▲

Live

Insights on Accuray Incorporated

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 96.49M → 118.06M (in $), with an average increase of 9.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -5.44M → 599.0K (in $), with an average increase of 301.8% per quarter

Performance

  • $3.52
    $3.61
    $3.58
    downward going graph

    1.68%

    Downside

    Day's Volatility :2.49%

    Upside

    0.83%

    downward going graph
  • $1.70
    $3.86
    $3.58
    downward going graph

    52.51%

    Downside

    52 Weeks Volatility :55.96%

    Upside

    7.25%

    downward going graph

Returns

PeriodAccuray IncorporatedSector (Health Care)Index (Russel 2000)
3 Months
28.57%
0.7%
-6.8%
6 Months
75.71%
-8.3%
-6.0%
1 Year
80.0%
-1.9%
-4.6%
3 Years
74.88%
25.3%
25.9%

Highlights

Market Capitalization
345.7M
Book Value
$0.57
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.11
PEG Ratio
0.08
Wall Street Target Price
8.3
Profit Margin
-2.32%
Operating Margin TTM
1.11%
Return On Assets TTM
0.65%
Return On Equity TTM
-19.14%
Revenue TTM
439.3M
Revenue Per Share TTM
4.67
Quarterly Revenue Growth YOY
-6.2%
Gross Profit TTM
160.0M
EBITDA
9.6M
Diluted Eps TTM
-0.11
Quarterly Earnings Growth YOY
-0.96
EPS Estimate Current Year
-0.06
EPS Estimate Next Year
0.1
EPS Estimate Current Quarter
-0.01
EPS Estimate Next Quarter
0.03

Analyst Recommendation

Buy
    91%Buy
    8%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Accuray Incorporated(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 131.84%

Current $3.58
Target $8.30

Company Financials

FY17Y/Y Change
Revenue
383.4M
↓ 3.86%
Net Income
-29.6M
↑ 15.98%
Net Profit Margin
-7.71%
↓ 1.31%
FY18Y/Y Change
Revenue
404.9M
↑ 5.6%
Net Income
-23.9M
↓ 19.2%
Net Profit Margin
-5.9%
↑ 1.81%
FY19Y/Y Change
Revenue
418.8M
↑ 3.43%
Net Income
-16.4M
↓ 31.25%
Net Profit Margin
-3.92%
↑ 1.98%
FY20Y/Y Change
Revenue
382.9M
↓ 8.56%
Net Income
3.8M
↓ 123.29%
Net Profit Margin
1.0%
↑ 4.92%
FY21Y/Y Change
Revenue
396.3M
↑ 3.49%
Net Income
-6.3M
↓ 264.91%
Net Profit Margin
-1.59%
↓ 2.59%
FY22Y/Y Change
Revenue
429.9M
↑ 8.48%
Net Income
-5.3M
↓ 15.27%
Net Profit Margin
-1.24%
↑ 0.35%
Q4 FY21Q/Q Change
Revenue
116.3M
↑ 8.22%
Net Income
179.0K
↓ 117.41%
Net Profit Margin
0.15%
↑ 1.11%
Q1 FY22Q/Q Change
Revenue
96.2M
↓ 17.29%
Net Income
-1.0M
↓ 684.36%
Net Profit Margin
-1.09%
↓ 1.24%
Q2 FY22Q/Q Change
Revenue
110.0M
↑ 14.41%
Net Income
-3.5M
↑ 230.02%
Net Profit Margin
-3.14%
↓ 2.05%
Q3 FY22Q/Q Change
Revenue
96.5M
↓ 12.3%
Net Income
-5.4M
↑ 57.85%
Net Profit Margin
-5.65%
↓ 2.51%
Q4 FY22Q/Q Change
Revenue
114.8M
↑ 18.93%
Net Income
-1.9M
↓ 65.61%
Net Profit Margin
-1.63%
↑ 4.02%
Q1 FY23Q/Q Change
Revenue
118.1M
↑ 2.88%
Net Income
599.0K
↓ 131.96%
Net Profit Margin
0.51%
↑ 2.14%
FY17Y/Y Change
Total Assets
406.5M
↓ 13.34%
Total Liabilities
359.9M
↓ 12.08%
FY18Y/Y Change
Total Assets
378.7M
↓ 6.82%
Total Liabilities
330.1M
↓ 8.29%
FY19Y/Y Change
Total Assets
438.2M
↑ 15.7%
Total Liabilities
388.3M
↑ 17.64%
FY20Y/Y Change
Total Assets
490.9M
↑ 12.04%
Total Liabilities
427.3M
↑ 10.04%
FY21Y/Y Change
Total Assets
480.1M
↓ 2.21%
Total Liabilities
411.3M
↓ 3.75%
FY22Y/Y Change
Total Assets
472.8M
↓ 1.51%
Total Liabilities
419.7M
↑ 2.04%
Q4 FY21Q/Q Change
Total Assets
475.5M
↓ 0.06%
Total Liabilities
424.5M
↓ 1.28%
Q1 FY22Q/Q Change
Total Assets
469.4M
↓ 1.28%
Total Liabilities
417.8M
↓ 1.57%
Q2 FY22Q/Q Change
Total Assets
472.8M
↑ 0.73%
Total Liabilities
419.7M
↑ 0.44%
Q3 FY22Q/Q Change
Total Assets
466.3M
↓ 1.37%
Total Liabilities
419.4M
↓ 0.07%
Q4 FY22Q/Q Change
Total Assets
468.8M
↑ 0.52%
Total Liabilities
417.0M
↓ 0.56%
Q1 FY23Q/Q Change
Total Assets
475.7M
↑ 1.48%
Total Liabilities
421.0M
↑ 0.96%
FY17Y/Y Change
Operating Cash Flow
-380.0K
↓ 101.13%
Investing Cash Flow
17.8M
↑ 115.72%
Financing Cash Flow
-54.5M
↑ 7104.49%
FY18Y/Y Change
Operating Cash Flow
18.3M
↓ 4923.95%
Investing Cash Flow
17.8M
↓ 0.32%
Financing Cash Flow
-27.5M
↓ 49.66%
FY19Y/Y Change
Operating Cash Flow
-29.6M
↓ 261.7%
Investing Cash Flow
-4.3M
↓ 124.27%
Financing Cash Flow
28.5M
↓ 203.72%
FY20Y/Y Change
Operating Cash Flow
-1.5M
↓ 95.04%
Investing Cash Flow
-3.7M
↓ 13.52%
Financing Cash Flow
26.7M
↓ 6.24%
FY21Y/Y Change
Operating Cash Flow
38.5M
↓ 2721.65%
Investing Cash Flow
-2.4M
↓ 35.65%
Financing Cash Flow
-28.8M
↓ 207.9%
FY22Y/Y Change
Operating Cash Flow
-2.4M
↓ 106.23%
Investing Cash Flow
-4.7M
↑ 96.62%
Financing Cash Flow
-15.4M
↓ 46.64%
Q4 FY21Q/Q Change
Operating Cash Flow
32.6M
↓ 479.2%
Investing Cash Flow
1.5M
↓ 200.0%
Financing Cash Flow
-13.5M
↑ 1251.0%
Q1 FY22Q/Q Change
Operating Cash Flow
-21.8M
↓ 166.75%
Investing Cash Flow
-1.1M
↓ 172.94%
Financing Cash Flow
-1000.0K
↓ 92.6%
Q2 FY22Q/Q Change
Operating Cash Flow
-4.6M
↓ 78.66%
Investing Cash Flow
-1.4M
↑ 31.45%
Financing Cash Flow
141.0K
↓ 114.1%
Q3 FY22Q/Q Change
Operating Cash Flow
46.0K
↓ 100.99%
Investing Cash Flow
-1.3M
↓ 8.88%
Financing Cash Flow
-4.4M
↓ 3195.74%
Q4 FY22Q/Q Change
Operating Cash Flow
-18.0M
↓ 39260.87%
Investing Cash Flow
-1.5M
↑ 20.6%
Financing Cash Flow
4.3M
↓ 197.94%
Q1 FY23Q/Q Change
Operating Cash Flow
24.6M
↓ 236.7%
Investing Cash Flow
-1.9M
↑ 23.79%
Financing Cash Flow
-1.5M
↓ 135.09%

Technicals Summary

Sell

Neutral

Buy

Accuray Incorporated is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Accuray Incorporated
Accuray Incorporated
6.65%
75.71%
80.0%
74.88%
-18.0%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Accuray Incorporated
Accuray Incorporated
NA
NA
0.08
-0.06
-0.19
0.01
0.0
0.57
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Accuray Incorporated
Accuray Incorporated
Buy
$345.7M
-18.0%
NA
-2.32%

Institutional Holdings

  • Archon Capital Management LLC

    6.39%

  • Neuberger Berman Group LLC

    5.47%

  • Vanguard Group Inc

    4.79%

  • BlackRock Inc

    3.51%

  • Royce & Associates, LP

    3.14%

  • Wellington Management Company LLP

    3.09%

Corporate Announcements

  • Accuray Incorporated Earnings

    Accuray Incorporated’s price-to-earnings ratio stands at None

    Read More

Company Information

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. Accuray is dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as they partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.

Organization
Accuray Incorporated
Employees
1044
CEO
Ms. Suzanne Winter M.B.A.
Industry
Health Technology

Discover More

FAQs